3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
16
Uterine Cervical Neoplasms
5
Stomach Neoplasms
5
Lung Neoplasms
5
Carcinoma, Transitional Cell
5
Carcinoma, Hepatocellular
5
Squamous Cell Carcinoma of Head and Neck
4
Sarcoma
4
Prostatic Neoplasms
4
Ovarian Neoplasms
4
Oropharyngeal Neoplasms
4
Multiple Myeloma
4
Esophageal Neoplasms
4
Cholangiocarcinoma
4
Urinary Bladder Neoplasms
3
Thyroid Neoplasms
3
Neuroendocrine Tumors
3
Neoplasm Metastasis
3
Lymphoma, Large B-Cell, Diffuse
3
Anus Neoplasms
3
Testicular Neoplasms
2
Solid Tumor
2
Pheochromocytoma
2
Paraganglioma
2
Pancreatic Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Melanoma
2
Leukemia, Myeloid, Acute
2
Laryngeal Neoplasms
2
Interventions
Cisplatin
7
Gemcitabine
6
pembrolizumab
4
Radiotherapy, Intensity-Modulated
4
toripalimab
2
Bevacizumab
2
tocilizumab
1
tislelizumab
1
spartalizumab
1
penpulimab
1
atezolizumab
1
Vitamin D
1
Tablets
1
Surveys and Questionnaires
1
Phantoms, Imaging
1
Oral Hygiene
1
Observation
1
Magnetic Resonance Spectroscopy
1
Immunotherapy
1
Immunohistochemistry
1
Immunoglobulin G
1
Fluorouracil
1
Disulfides
1
Dexamethasone
1
Chemoradiotherapy
1
Cetuximab
1
Carboplatin
1
Capecitabine
1
Blood Specimen Collection
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Nasopharyngeal Neoplasms
×
Fluorodeoxyglucose F18
×
1 year
×
Clear all
No trials found.